Weight loss pills(CP00078.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Weight loss pills
CP00078.US
News
View More

Top Pharmaceutical Stocks To Follow Today - January 18th

AstraZeneca, Eli Lilly, Novo Nordisk, AbbVie, and Pfizer are highlighted as top pharmaceutical stocks to watch today, according to MarketBeat. These companies are involved in the research, development, and sale of prescription drugs, with their stocks evaluated based on drug pipelines and regulatory approvals. AstraZeneca focuses on various therapeutic areas, while Eli Lilly specializes in diabetes and obesity treatments. Novo Nordisk operates in diabetes care, AbbVie offers treatments for autoimmune diseases, and Pfizer provides a range of biopharmaceutical products, including COVID-19 vaccines.

Market Beat·
US
AZN
+0.43%
US
ABBV
-0.31%
US
NVO
+9.12%
Market Beat·
US
AZN
+0.43%
US
ABBV
-0.31%
US
NVO
+9.12%

Notable healthcare headlines for the week: Eli Lilly, UnitedHealth, and Boston Scientific in focus

Wall Street experienced marginal losses on Friday, reflecting a week of similar trends. The Dow Jones Industrial Average fell by 0.17% to close at 49,359.33 points, while the S&P 500 and Nasdaq Composite both slipped by 0.06%, finishing at 6,940.01 points. Notable healthcare companies like Eli Lilly, UnitedHealth, and Boston Scientific were in focus during this period.

MSN·
US
BSX
-2.18%
US
UNH
-2.34%
US
LLY
+0.53%
MSN·
US
BSX
-2.18%
US
UNH
-2.34%
US
LLY
+0.53%

Eli Lilly and Company $LLY Shares Acquired by Maryland State Retirement & Pension System

Maryland State Retirement & Pension System increased its holdings in Eli Lilly and Company (NYSE:LLY) by 2.7% in Q3, owning 39,879 shares valued at $30.4 million. Other institutional investors also raised their stakes. Analysts have a consensus "Buy" rating for LLY, with price targets ranging from $950 to $1,300. Eli Lilly's stock opened at $1,038.26, with a 1-year high of $1,133.95. The company reported Q3 earnings of $7.02 per share, exceeding estimates, with revenue of $17.6 billion, up 53.9% year-over-year.

Market Beat·
US
LLY
+0.53%
Market Beat·
US
LLY
+0.53%

Sequoia Financial Advisors LLC Purchases 6,021 Shares of Eli Lilly and Company $LLY

Sequoia Financial Advisors LLC increased its stake in Eli Lilly and Company (NYSE: LLY) by 4.3% in Q3, acquiring an additional 6,021 shares, bringing its total to 146,222 shares valued at $111.57 million. Other investors also adjusted their positions, with significant new stakes from firms like Sumitomo Mitsui and Evolution Wealth Management. Eli Lilly's recent developments include a partnership with Nvidia for an AI-enabled research facility and progress in its drug pipeline, despite facing FDA delays on an obesity drug and ongoing litigation risks.

Market Beat·
US
LLY
+0.53%
Market Beat·
US
LLY
+0.53%

Stephens Inc. AR Lowers Holdings in Novo Nordisk A/S $NVO

Stephens Inc. AR has significantly reduced its stake in Novo Nordisk A/S by 83.3% in Q3, now holding 25,128 shares valued at $1.39 million. Other institutional investors have also adjusted their positions, with Lockheed Martin Investment Management increasing its stake by 179.4%. Novo Nordisk's stock performance shows a market cap of $278.26 billion and a P/E ratio of 18.12. The company reported earnings of $1.02 per share, exceeding estimates, while analysts remain cautious about long-term demand for its products amid legal and valuation concerns.

Market Beat·
US
NVO
+9.12%
Market Beat·
US
NVO
+9.12%
Posts
View More

Tsmc will fly to the moon, let’s go!

© 2026 Longbridge｜Disclaimer